Skip to main content
Clinical Trials/TCTR20240618007
TCTR20240618007
Recruiting
Not Applicable

Comparison of clinical outcome and radiographic between bone morphogenetic protein-2 and beta-Tricalcium phosphate plus iliac bone graft in extreme lateral interbody fusion surgery : Ambidirectional cohort study

Department of orthopedics surgery and physical therapy, Faculty of medicine Siriraj hospital0 sites48 target enrollmentJune 18, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Fusion rate in patient who has spondylosis or spondylolithesis, and surgery lumbar spine by XLIF surgery (Extreme lateral interbody fusion) comparing between use BMP-2 and beta-tricalcium phosphate
Sponsor
Department of orthopedics surgery and physical therapy, Faculty of medicine Siriraj hospital
Enrollment
48
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 18, 2024
End Date
December 31, 2024
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Department of orthopedics surgery and physical therapy, Faculty of medicine Siriraj hospital

Eligibility Criteria

Inclusion Criteria

  • 1\. Patient who was diagnosed : Lumbar spondylosis, 2\. Patient who was diagnosed : Lumbar spondylolithesis, 3\. All patients who have undergone surgery XLIF

Exclusion Criteria

  • 1\. Patient who has severe complication in post\-op surgery such as : Sepsis, Hemodynamic unstable, Stroke
  • 2\. Complication at post\-operative follow up such as : Surgical site infection, Implant failure, Malignant at spine

Outcomes

Primary Outcomes

Not specified

Similar Trials